Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2012 Jun 26;23(4):276–284. doi: 10.1016/j.euroneuro.2012.05.009

Table 1.

Baseline Characteristics of Remitters, Non-remitters and Healthy Subjects.

Remitters (n = 7) Non-remitters (n = 6) Healthy Subjects (n = 10) Sig. a

Mean ± SEM Mean ± SEM Mean ± SEM
Age 31.9 (5.0) 31.2 (1.9) 30.3 (2.4) .94
Female (N; %) 4 (57%) 3 (50%) 6 (60%) .93
BMI 22.81 (1.81) 22.82 (1.78) 21.94 (0.61) .90
IQ 119.3 (3.2) 124.8 (1.0) 118.3 (4.6) .53
Age of Onset 17.3 (4.6) 15.0 (2.0) N/A .68
Duration of Illness 14.6 (4.8) 16.2 (2.3) N/A .78
Psychotropic-naïve (N; %) 3 (43%) 2 (33%) N/A .72
HAM-A Baseline 18.3 (0.6) 21.2 (1.7) 1.6 (0.5) < .001b
PSWQ Baseline 65.9 (3.4) 63.2 (3.6) 33.7 (3.1) < .001c
a

ANOVA, Independent t-test or Chi square test (significance set at p ≤ .05);

b

Post-Hoc analysis showed no significant HAM-A difference between Remitters and Non-remitters (p = .14);

c

Post-Hoc analysis showed no significant PSWQ difference between Remitters and Non-remitters (p = 1.0);

Abbreviations: BMI: Body Mass Index; IQ: was determined with the Wechsler Abbreviated Scale of Intelligence; HAM-A, Hamilton Anxiety Rating Scale; PSWQ, Penn State Worry Questionnaire.